Transparency Market Research Report Added "Human Microbiome Market" to its database.

Albany, NY -- (SBWire) -- 08/25/2016 --A study on the global human microbiome market by Transparency Market Research (TMR) reports that the increasing incidence of chronic medical conditions such as diabetes, obesity, cancer, cardiovascular diseases, and neurological disorders is the key driving force behind the growing demand for human microbiome across the world. The report, titled "Human Microbiome Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023," further states that the rising awareness among people regarding the benefits of microbiome products is also adding to the increasing demand for human microbiome. However, strict government regulations pertaining to the usage of microbiome products may perturb the growth trajectory of this market in the coming years.

On the other hand, the continuing advancement in biomedical sciences is likely to create opportunities for the application of human microbiome over the next few years. The increasing interest of leading players in mergers and acquisitions is expected to propel this market signifcanlty during the forecast period, notes the market study.

In this report, the global market for human microbiome has been studied on the basis of disease, product, application, and region. Geographically, the worldwide market for human microbiome has been segmented into Europe, North America, Asia Pacific and the Rest of the World. North America and Europe have been leading the demand for human microbiome over the recent past and are expected to do so during the forecast period.

The continual improvement in the biotechnological and microbiological research infrastructure has been driving the growth of the human microbiome market in these regions since the last few years. Over the coming years, the mounting risk of lifestyle disorders is likely to propel this market in Europe and North America, states the research report.

Download Free exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3999

Based on disease, the report classifies the global market into autoimmune ailments, allergic conditions, diarrhea, obesity, cancer, diabetes, and various other diseases. Based on product, the market has been segmented into probiotics, prebiotics, drugs, devices, and medical foods. Furthermore, the medical food segment has been categorized into oral rehydration products, nutritionally complete formulae, nutritionally incomplete formulae, and formulae for metabolic disorders. Diagnostics and therapeutics have been identified as the two main application areas of human microbiome in this research study.

The leading players in the worldwide human microbiome market are ActoGenix, Enterome Bioscience SA, DuPont, Metabiomics Corp., MicroBiome Therapeutics LLC, Merck & Co. Inc., OptiBiotix Health Plc, Ritter Pharmaceuticals Inc., Osel Inc., Second Genome Inc., ViThera Pharmaceuticals Inc., Vedanta BioScience Inc., and Yakult Honsha Co. Ltd., states the report.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: 518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/